- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04646733
Effect of a Low-carbohydrate, High-protein Energy-restricted Diet on Weight and Body Composition Using DXA
Effect of a Low-carbohydrate, High-protein Ketogenic Diet on Weight and Body Composition: a Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The patients (n = 60) are invited through posters and social networks to recruit a group of 40 overweight subjects (20% above their ideal weight). The protocol is explained in detail to each one, and the patient and two witnesses sign the informed consent. Subjects are assigned to one of two groups: group A: high protein diet (HPD) and group B: non-high protein diet (NHPD). The NHPD is designed according to Mexican nutrition guidelines according to sex and age.
The main anthropometric and biochemical measurements and diet monitoring are performed in the body composition laboratory of the Faculty of Sports Organization (FOD). Four technicians (nutritionists) are in charge of taking the measurements and recording the data. The principal investigators review the quality of the information and the correct completion of the records. Each file will be assigned an identification number. Other nutritionists (graduate students) will be in charge of auditing the information according to the protocol guidelines. Principal Investigators will resolve any discrepancies between technicians and graduate students to ensure data recording, deletion, or reevaluation.
Each patient is asked for a prior medical examination before entering the study. The data from the external medical practitioner are compared with those provided by the patient for the present study.
The main anthropometric variables are measured with the international ISAK methodology. The DXA equipment is calibrated daily, and the result is analyzed and analyzed by a researcher who evaluates whether the measurement is reliable.
The data is recorded in printed formats that are immediately scanned to maintain readability. Later, they are recorded in an Excel sheet with the patient's identification number. In each measurement session, the database is analyzed for abnormal, extreme or unlikely data. Two independent researchers are responsible for reviewing the database every day.
Each patient is cared for by a nutrition student who accompanies him in the basic needs, clothing and transfers to the measurement equipment. At the end of the evaluation, patients receive a complimentary meal and free transportation home.
Patients are monitored through WhatsApp to verify the presence of adverse events with the diet. Also, for any questions with the procedures. All procedures are recorded in paper and electronic form. In addition, they are given an additional number in case of medical emergency or consultation with a nutritionist.
The sample size will be limited in the first stage to 30 patients. Measurements and preliminary analysis will be obtained at 0, day four and day fifteen. The last two measurements will be taken on day 42 and until the subjects reach their ideal body weight.
In the case of missing data or defective quality record, subjects will be removed.
Regarding the statistical analysis, multiple linear regression will be used, where the groups and measurements will be compared on the different measurement days. As covariates, covariates will be incorporated as initial values, age, sex, BMI, among others, will be adjusted. Descriptive statistics will be added.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
N.l.
-
Monterrey, N.l., Mexico, 64460
- Facultad de Organización Deportiva, FOD, Universidad Autónoma de Nuevo León
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- individuals between the ages of 20 and 30
- who were not currently consuming any drugs or were on diet or exercise treatment.
- patients must have 120% or more of the ideal weight until a BMI of 35.
Exclusion Criteria:
- with no cardiovascular disease, kidney, intestinal or liver disease.
- cholesterol (≥ 200 mg/dL)
- high triglycerides (≥ 150mg/dL)
- glucose (≥ 126mg /dL)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Protein Diet Group
The high protein diet (HPD) group is instructed to follow a low carbohydrate, high protein ketogenic diet.
|
The high protein diet (HPD) group is instructed to follow a low carbohydrate, high protein ketogenic diet.
This diet has 4 phases, two of weight loss until reaching the ideal weight (attack and cruise) and two of maintenance (consolidation and stabilization).
During the first 2 phases, it allows 100 foods (28 vegetables).
The first phase lasts 3-10 days and 72 high-protein, low-fat foods are allowed.
In the second phase, there are alternate days between consuming the low glycemic index vegetables plus protein and the next day with just protein.
The first two phases are ad libitum.
Phase 3 (consolidation) aims to avoid rebound and begins the introduction of complex carbohydrates and legumes in individual servings.
In phase 4 (stabilization), the subject returns to a free diet.
However, three basic rules are introduced: protein one day a week, the exercise of at least 20 min/day (optional) and consumption of 3 tablespoons of oat bran/day.
|
|
Active Comparator: No High Protein Diet Group
No high protein diet (NHPD) group received an oat beverage consisted of 55 g of oats in 250 ml of water.
|
No high protein diet (NHPD) group received an oat beverage consisted of 55 g of oats in 250 ml of water.
Beverage contained 1.6 g of betaG per portion according to FDA recommendations corresponding to 50 % of betaG required per day.
Weekly bags containing oat mixture were provided on day 0 and in the third week of the trial.
No additional instructions about diet, exercise program or pharmacological treatment was implemented.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body fat
Time Frame: Baseline to three months.
|
Body fat measurements by DXA
|
Baseline to three months.
|
|
Lean mass
Time Frame: Baseline to three months
|
Lean mass measurements by DXA
|
Baseline to three months
|
|
Weight lost
Time Frame: Baseline to three months
|
Weight lost through the various phases
|
Baseline to three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body water
Time Frame: Baseline to three months
|
Body water changes measured by bioelectrical impedance
|
Baseline to three months
|
|
Resting energy expenditure
Time Frame: Baseline to three months
|
Energy expenditure measure by calorimetry.
|
Baseline to three months
|
|
Caloric and macronutrient intake
Time Frame: Baseline to three months
|
Energy and macronutrient distribution intake.
To estimate the nutrient intake is used as a weighted dietary record.
Each individual weighs the items on a scale before and after consumption by three consecutive days.
Scales has a precision of 1 g.
The persons record all the food and beverages consumed, including ingredients, preparation method, and quantity of the food consumed and not consumed.
We proportionate all the instruction and description for the individual before assigning the task to record.
This procedure ensures the accuracy and reliability of the information provided.
Records are processed with the software DietOrganizer (R) to obtain caloric and macronutrient intake.
|
Baseline to three months
|
|
Serum fasting triglycerides
Time Frame: Baseline to three months
|
Serum fasting triglicerides are taken after 9 to 12 h, milligrams per deciliter (mg/dL).
|
Baseline to three months
|
|
Serum fasting glucose
Time Frame: Baseline to three months
|
Serum fasting glucose is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
|
Baseline to three months
|
|
Serum fasting total cholesterol
Time Frame: Baseline to three months
|
Serum total cholesterol is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
|
Baseline to three months
|
|
Serum fasting HDL cholesterol
Time Frame: Baseline to three months
|
Serum total cholesterol is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
|
Baseline to three months
|
|
Serum fasting albumin
Time Frame: Baseline to three months
|
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
|
Baseline to three months
|
|
Serum fasting total protein
Time Frame: Baseline to three months
|
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
|
Baseline to three months
|
|
Serum fasting total hemoglobin
Time Frame: Baseline to three months
|
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
|
Baseline to three months
|
|
hand strenght with a dynamometer
Time Frame: Baseline to three months
|
Hand strength is measured with a standardized protocol using a chair.
A digital dynamometer is employed, and units are expressed as kg.
|
Baseline to three months
|
|
triceps skinfold with a plicometer
Time Frame: Baseline to three months
|
triceps skinfold is measured with a plicometer and the units are expresed as mm
|
Baseline to three months
|
|
waist perimeter
Time Frame: Baseline to three months
|
waist perimeter is measured with a measuring tape and units are expresed as cm
|
Baseline to three months
|
|
mid-arm perimeter
Time Frame: Baseline to three months
|
mid arm perimeter is measured with a measuring tape and units are expresed as cm
|
Baseline to three months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Anton SD, Hida A, Heekin K, Sowalsky K, Karabetian C, Mutchie H, Leeuwenburgh C, Manini TM, Barnett TE. Effects of Popular Diets without Specific Calorie Targets on Weight Loss Outcomes: Systematic Review of Findings from Clinical Trials. Nutrients. 2017 Jul 31;9(8):822. doi: 10.3390/nu9080822.
- Atallah R, Filion KB, Wakil SM, Genest J, Joseph L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. Long-term effects of 4 popular diets on weight loss and cardiovascular risk factors: a systematic review of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):815-27. doi: 10.1161/CIRCOUTCOMES.113.000723. Epub 2014 Nov 11.
- Seid H, Rosenbaum M. Low Carbohydrate and Low-Fat Diets: What We Don't Know and Why we Should Know It. Nutrients. 2019 Nov 12;11(11):2749. doi: 10.3390/nu11112749.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- erik2020DUKAN
- REPRIN-FOD-76 (Other Identifier: Assigned by the Faculty of Sports Organization)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
Medical University of ViennaCompleted
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Completed
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on High Protein Diet Group
-
Rio de Janeiro State UniversityRio de Janeiro State Research Supporting Foundation (FAPERJ)Completed
-
German Institute of Human NutritionUniversity Hospital Tuebingen; Ernst von Bergmann Hospital; Ministry of Food... and other collaboratorsCompletedMetabolic Diseases | Obesity | Diabetes Mellitus, Type 2 | Nutrition Disorders | Body Weight | Metabolic Syndrome xGermany
-
Oslo University HospitalCompletedSmoking | Obesity | OverweightNorway
-
Mexican National Institute of Public HealthCompletedWeight Loss | Metabolic Syndrome XMexico
-
Prince Sattam Bin Abdulaziz UniversityCompleted
-
Wageningen UniversityTop Institute Food and NutritionCompletedIdentify New Biomarkers in Blood or Urine After Consumption of Meat Protein, Dairy Protein and Grain Protein in Healthy Subjects.Netherlands
-
University of BonnFederal Ministry of Food and Agriculture (BMEL); Federal Office for Agriculture...CompletedCardiovascular Diseases | Metabolic SyndromeGermany
-
University of TennesseeUnknownInflammation | ObesityUnited States
-
TC Erciyes UniversityTübitakNot yet recruitingEffect of High Protein Diet on Endoplasmic Reticulum Stress
-
Chang Gung Memorial HospitalCompletedIschemic Stroke | Diet, Healthy | Muscle LossTaiwan